92 related articles for article (PubMed ID: 3002510)
1. [Inorganic pyrophosphates and parathormone in hypophosphatasia. Study of a family].
Taillard F; Desbois JC; Gueris J; Delépine N; Lacour B; Grétillat F; Wyart D
Biomed Pharmacother; 1985; 39(5):236-41. PubMed ID: 3002510
[TBL] [Abstract][Full Text] [Related]
2. [Congenital hypophosphatasia].
Terheggen HG; Wischermann A
Monatsschr Kinderheilkd; 1984 Jul; 132(7):512-22. PubMed ID: 6147751
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of adult hypophosphatasia. Report of severe and mild cases.
Weinstein RS; Whyte MP
Arch Intern Med; 1981 May; 141(6):727-31. PubMed ID: 7235780
[TBL] [Abstract][Full Text] [Related]
4. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
Roof BS; Piel CF; Gordan GS
Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
[No Abstract] [Full Text] [Related]
5. Metabolic bone disease in children.
Steendijk R
Clin Orthop Relat Res; 1971; 77():247-75. PubMed ID: 4335242
[No Abstract] [Full Text] [Related]
6. [Familial hypocalciuric hypercalcemia: two case reports (author's transl)].
Sereni D; Chevalier P; Cremer GA; Boissonnas A; Dubost C; Laroche C
Ann Med Interne (Paris); 1982; 133(4):281-4. PubMed ID: 7114660
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphatasia: biochemical screening of a Dutch kindred and evidence that urinary excretion of inorganic pyrophosphate is a marker for the disease.
Macfarlane JD; Poorthuis BJ; van de Kamp JJ; Russell RG; Caswell AM
Clin Chem; 1988 Sep; 34(9):1937-41. PubMed ID: 2843309
[TBL] [Abstract][Full Text] [Related]
8. Familial benign hypercalcaemia. Study of a large family.
Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
[TBL] [Abstract][Full Text] [Related]
9. [Hormonal interactions of parathormone and calcium metabolism].
Kovács L
Orv Hetil; 2003 Jan; 144(1):3-12. PubMed ID: 12635347
[TBL] [Abstract][Full Text] [Related]
10. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
[TBL] [Abstract][Full Text] [Related]
11. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.
Baumgartner-Sigl S; Haberlandt E; Mumm S; Scholl-Bürgi S; Sergi C; Ryan L; Ericson KL; Whyte MP; Högler W
Bone; 2007 Jun; 40(6):1655-61. PubMed ID: 17395561
[TBL] [Abstract][Full Text] [Related]
12. Serum alkaline phosphatase, serum pyrophosphatase, phosphorylethanolamine and inorganic pyrophosphate in plasma and urine. A genetic and clinical study of hypophosphatasia.
Sørensen SA; Flodgaard H; Sørensen E
Monogr Hum Genet; 1978; 10():66-9. PubMed ID: 214699
[No Abstract] [Full Text] [Related]
13. The urinary excretion of inorganic pyrophosphate in hyperparathyroidism, hyperthyroidism, Paget's disease and other disorders of bone metabolism.
Russell RG; Hodgkinson A
Clin Sci; 1969 Jun; 36(3):435-43. PubMed ID: 4307562
[No Abstract] [Full Text] [Related]
14. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
[TBL] [Abstract][Full Text] [Related]
15. Neonatal hypophosphatasia and seizures. A case report.
Smilari P; Romeo DM; Palazzo P; Meli C; Sorge G
Minerva Pediatr; 2005 Oct; 57(5):319-23. PubMed ID: 16205618
[TBL] [Abstract][Full Text] [Related]
16. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
[TBL] [Abstract][Full Text] [Related]
17. Observations on the course of untreated primary hyperparathyroidism.
Corlew DS; Bryda SL; Bradley EL; DiGirolamo M
Surgery; 1985 Dec; 98(6):1064-71. PubMed ID: 3878002
[TBL] [Abstract][Full Text] [Related]
18. Berson and Yalow's radioimmunoassay for parathyroid hormone (PTH): a clinical progress report.
Roof BS; Gordan GS; Goldman L; Piel CF
Mt Sinai J Med; 1973; 40(3):433-47. PubMed ID: 4351492
[No Abstract] [Full Text] [Related]
19. Hypophosphatasia: diagnostic application of linked DNA markers in the dominantly inherited adult form.
Iqbal SJ; Plaha DS; Linforth GH; Dalgleish R
Clin Sci (Lond); 1999 Jul; 97(1):73-8. PubMed ID: 10369796
[TBL] [Abstract][Full Text] [Related]
20. [The course of parathyroid hormone following an operation for hyperparathyroidism].
Walgenbach S; Junginger T
Zentralbl Chir; 1985; 110(24):1544-9. PubMed ID: 4090786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
